Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Identification of a new aggressive axis driven by ciliogenesis and absence of VDAC1-ΔC in clear cell Renal Cell Carcinoma patients.

Fabbri L, Dufies M, Lacas-Gervais S, Gardie B, Gad-Lapiteau S, Parola J, Nottet N, Meyenberg Cunha de Padua M, Contenti J, Borchiellini D, Ferrero JM, Leclercq NR, Ambrosetti D, Mograbi B, Richard S, Viotti J, Chamorey E, Sadaghianloo N, Rouleau M, Craigen WJ, Mari B, Clavel S, Pagès G, Pouysségur J, Bost F, Mazure NM.

Theranostics. 2020 Feb 3;10(6):2696-2713. doi: 10.7150/thno.41001. eCollection 2020.

2.

[Preoperative breast imaging review: Interests and limits of specialized validation in oncology].

Flory V, Lévy G, Viotti J, Schiappa R, Elkind L, Ghez C, Pellegrin A, Occelli A, Dejode M, Delpech Y, Fouché Y, Figl A, Machiavello JC, Haudebourg J, Peyrottes I, Chapellier C, Barranger E.

Bull Cancer. 2020 Mar;107(3):295-307. doi: 10.1016/j.bulcan.2019.11.013. Epub 2020 Feb 27. French.

PMID:
32115178
3.

Cetuximab is efficient and safe in patients with advanced cutaneous squamous cell carcinoma: a retrospective, multicentre study.

Montaudié H, Viotti J, Combemale P, Dutriaux C, Dupin N, Robert C, Mortier L, Kaphan R, Duval-Modeste AB, Dalle S, De Quatrebarbes J, Stefan A, Brunet-Possenti F, Kogay M, Picard-Gauci A, Poissonnet G, Peyrade F.

Oncotarget. 2020 Jan 28;11(4):378-385. doi: 10.18632/oncotarget.27434. eCollection 2020 Jan 28.

4.

Differential Effect on Hippocampal Synaptic Facilitation by the Presynaptic Protein Mover.

Viotti JS, Dresbach T.

Front Synaptic Neurosci. 2019 Nov 15;11:30. doi: 10.3389/fnsyn.2019.00030. eCollection 2019.

5.

The Calmodulin Binding Region of the Synaptic Vesicle Protein Mover Is Required for Homomeric Interaction and Presynaptic Targeting.

Akula AK, Zhang X, Viotti JS, Nestvogel D, Rhee JS, Ebrecht R, Reim K, Wouters F, Liepold T, Jahn O, Bogeski I, Dresbach T.

Front Mol Neurosci. 2019 Nov 8;12:249. doi: 10.3389/fnmol.2019.00249. eCollection 2019.

6.

Iron deficiency during first-line chemotherapy in metastatic cancers: a prospective epidemiological study.

Saint A, Viotti J, Borchiellini D, Hoch B, Raimondi V, Hebert C, Largillier R, Evesque L, Follana P, Ferrero JM, Delaby C, Schiappa R, Chamorey E, Barriere J.

Support Care Cancer. 2020 Apr;28(4):1639-1647. doi: 10.1007/s00520-019-04938-3. Epub 2019 Jul 6.

PMID:
31278463
7.

Managing Missing Data in the Hospital Survey on Patient Safety Culture: A Simulation Study.

Boussat B, François O, Viotti J, Seigneurin A, Giai J, François P, Labarère J.

J Patient Saf. 2019 Mar 22. doi: 10.1097/PTS.0000000000000595. [Epub ahead of print]

PMID:
30908454
8.

Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5.

Giuliano S, Dufies M, Ndiaye PD, Viotti J, Borchiellini D, Parola J, Vial V, Cormerais Y, Ohanna M, Imbert V, Chamorey E, Rioux-Leclercq N, Savina A, Ferrero JM, Mograbi B, Pagès G.

Theranostics. 2019 Jan 30;9(4):1181-1199. doi: 10.7150/thno.29093. eCollection 2019.

9.

Quantifying the Heterogeneous Distribution of a Synaptic Protein in the Mouse Brain Using Immunofluorescence.

Wallrafen R, Dresbach T, Viotti JS.

J Vis Exp. 2019 Jan 29;(143). doi: 10.3791/58940.

PMID:
30774137
10.

Apparent calcium dependence of vesicle recruitment.

Ritzau-Jost A, Jablonski L, Viotti J, Lipstein N, Eilers J, Hallermann S.

J Physiol. 2018 Oct;596(19):4693-4707. doi: 10.1113/JP275911. Epub 2018 Aug 7.

11.

Impact of HPV-associated p16-expression and other clinical factors on therapeutic decision-making in patients with oropharyngeal cancer: A GETTEC multicentric study.

Culié D, Garrel R, Viotti J, Schiappa R, Chamorey E, Fakhry N, Lallemant B, Vergez S, Dupret-Bories A, Dassonville O, Poissonnet G, Santini J, Peyrade F, Benezery K, Sudaka A, Jourdan-Soulier F, Chapel F, Guelfucci B, Bozec A.

Eur J Surg Oncol. 2018 Dec;44(12):1908-1913. doi: 10.1016/j.ejso.2018.05.022. Epub 2018 May 25.

PMID:
29871820
12.

Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma.

Dufies M, Nollet M, Ambrosetti D, Traboulsi W, Viotti J, Borchiellini D, Grépin R, Parola J, Giuliano S, Helley-Russick D, Bensalah K, Ravaud A, Bernhard JC, Schiappa R, Bardin N, Dignat-George F, Rioux-Leclercq N, Oudard S, Négrier S, Ferrero JM, Chamorey E, Blot-Chabaud M, Pagès G.

Theranostics. 2018 Mar 28;8(9):2447-2458. doi: 10.7150/thno.23002. eCollection 2018.

13.

CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas.

Dufies M, Giuliano S, Viotti J, Borchiellini D, Cooley LS, Ambrosetti D, Guyot M, Ndiaye PD, Parola J, Claren A, Schiappa R, Gal J, Frangeul A, Jacquel A, Cassuto O, Grépin R, Auberger P, Bikfalvi A, Milano G, Escudier B, Rioux-Leclercq N, Porta C, Negrier S, Chamorey E, Ferrero JM, Pagès G.

Br J Cancer. 2017 Sep 26;117(7):947-953. doi: 10.1038/bjc.2017.276. Epub 2017 Aug 29.

14.

Optimizing drug development in oncology by clinical trial simulation: Why and how?

Gal J, Milano G, Ferrero JM, Saâda-Bouzid E, Viotti J, Chabaud S, Gougis P, Le Tourneau C, Schiappa R, Paquet A, Chamorey E.

Brief Bioinform. 2018 Nov 27;19(6):1203-1217. doi: 10.1093/bib/bbx055. Review.

PMID:
28575140
15.

Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study.

Zwarthoed C, El-Galaly TC, Canepari M, Ouvrier MJ, Viotti J, Ettaiche M, Viviani S, Rigacci L, Trentin L, Rusconi C, Luminari S, Cantonetti M, Bolis S, Borra A, Darcourt J, Salvi F, Subocz E, Tajer J, Kulikowski W, Malkowski B, Zaucha JM, Gallamini A.

J Nucl Med. 2017 Aug;58(8):1249-1254. doi: 10.2967/jnumed.116.184218. Epub 2017 Jan 26.

16.

Corrigendum to "C-reactive protein levels after cardiac arrest in patients treated with therapeutic hypothermia" [Resuscitation 85 (2014) 932-938].

Dell'anna AM, Viotti JB, Beumier M, Orbegozo-Cortes D, Donadello K, Scolletta S, Vincent JL, Taccone FS.

Resuscitation. 2016 Nov;108:111. doi: 10.1016/j.resuscitation.2016.09.001. Epub 2016 Sep 7. No abstract available.

PMID:
27614194
17.

Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity.

Viotti J, Duplan E, Caillava C, Condat J, Goiran T, Giordano C, Marie Y, Idbaih A, Delattre JY, Honnorat J, Checler F, Alves da Costa C.

Oncogene. 2014 Apr 3;33(14):1764-75. doi: 10.1038/onc.2013.124. Epub 2013 May 6.

PMID:
23644658
18.

ER-stress-associated functional link between Parkin and DJ-1 via a transcriptional cascade involving the tumor suppressor p53 and the spliced X-box binding protein XBP-1.

Duplan E, Giaime E, Viotti J, Sévalle J, Corti O, Brice A, Ariga H, Qi L, Checler F, Alves da Costa C.

J Cell Sci. 2013 May 1;126(Pt 9):2124-33. doi: 10.1242/jcs.127340. Epub 2013 Feb 27.

19.

Parkin differently regulates presenilin-1 and presenilin-2 functions by direct control of their promoter transcription.

Duplan E, Sevalle J, Viotti J, Goiran T, Bauer C, Renbaum P, Levy-Lahad E, Gautier CA, Corti O, Leroudier N, Checler F, da Costa CA.

J Mol Cell Biol. 2013 Apr;5(2):132-42. doi: 10.1093/jmcb/mjt003. Epub 2013 Jan 28.

PMID:
23359614
20.

HIV/HCV coinfection in Infectious Disease Units in Mozambique and Brazil: a comparative study.

Rodrigues Mda C, Viotti JB, Braga RF, Lourenço LF, Antunes CM, Lambertucci JR.

Rev Soc Bras Med Trop. 2008 Sep-Oct;41(5):518. No abstract available.

21.

[Perforated colonic diverticulitis: its diagnosis and treatment. Our experience].

Jaremczuk NS, Viotti JA, Acevedo JA, Lódolo A, Garibotti JJ.

Rev Fac Cien Med Univ Nac Cordoba. 1992;50(1):31-3. Spanish.

PMID:
1344185
22.

[Actinomycosis of the abdominal wall. Report of a case].

Viotti JA, Jaremczuk NS, Lódolo A, Giraudo R.

Rev Fac Cien Med Univ Nac Cordoba. 1991;49(1):35-8. Spanish.

PMID:
1843359

Supplemental Content

Loading ...
Support Center